ArticleJournal for immunotherapy of cancer2022

Albendazole induces immunotherapy response by facilitating ubiquitin-mediated PD-L1 degradation.

Lin Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.